• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP BR; BR (CA 27.29) IMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP BR; BR (CA 27.29) IMMUNOASSAY Back to Search Results
Model Number N/A
Device Problem No Apparent Adverse Event (3189)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/04/2019
Event Type  malfunction  
Manufacturer Narrative
Customer provided results for heterophilic ab testing: (b)(6).Siemens healthcare diagnostics is investigating.Mdr 1219913-2019-00046 (for test results on (b)(6) 2019) was filed for the same event.
 
Event Description
A falsely high patient sample result of >450 u/ml was obtained on (b)(6) 2019 using advia centaur xp br ((b)(4)) assay with reagent lot 047234 and calibrator lot cg40.The customer repeated testing of the sample with x10 and x20 automatic onboard dilutions and obtained over-dilution errors and repeated with a manual dilution, at 1:5 which resulted at 34.5 u/ml.Repeat testing was performed on (b)(6) 2019 resulting in an additional high neat result and over-dilution error.The sample was later run on the same day on a different advia centaur and resulted at 7.24 u/ml without over-dilution errors.False high results were not reported to the physician.There was no report of adverse health consequences due to the high patient result.
 
Manufacturer Narrative
The following mdrs were filed on march 28, 2019 reporting falsely high results with the br (ca 27.29) assay on the advia centaur xp; mdr 1219913-2019-00046 (for test results on 2/28/2019) (for test results on 3/4/2019).April 4, 2019 - additional information.Customer service engineer (cse) inspected instruments and no issues were identified.The customer performed a post-service precision study using qc on both instruments and results were acceptable per customer response (no results provided).Siemens investigation is complete.Based on the information provided, siemens is unable to rule out a sample specific issue.No product problem has been identified.The customer is operational.Mdr 1219913-2019-00046 supplemental report 1 (for test results on 2/28/2019) was filed for the same event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR XP BR
Type of Device
BR (CA 27.29) IMMUNOASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591 5097
MDR Report Key8462176
MDR Text Key145246820
Report Number1219913-2019-00049
Device Sequence Number1
Product Code MOI
UDI-Device Identifier00630414196657
UDI-Public00630414196657
Combination Product (y/n)N
PMA/PMN Number
K982680
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 04/26/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/14/2019
Device Model NumberN/A
Device Catalogue Number10333349
Device Lot Number047234
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/04/2019
Initial Date FDA Received03/28/2019
Supplement Dates Manufacturer Received04/04/2019
Supplement Dates FDA Received04/26/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-